12½ years’ jail for ex-Macau lawmaker Au Kam-san in city’s first national security trial
South China Morning Post's headline. Reported by South China Morning Post.
What South China Morning Post reported
Former Macau lawmaker Au Kam-san has been convicted on five out of seven charges in the city’s first national security trial, with the court handing down a 12½-year prison sentence. The Court of First Instance in Macau on Friday found the 69-year-old guilty on four counts under the city’s national s
The publisher's own words, quoted for review. Every outlet carrying the story is listed below with its link.
12½ years’ jail for ex-Macau lawmaker Au Kam-san in city’s first national security trial. Former Macau lawmaker Au Kam-san has been convicted on five out of seven charges in the city’s first national security trial, with the court handing down a 12½-year prison sentence. The Court of First Instance in Macau on Friday found the 69-year-old guilty on four counts under the city’s national s Covered by 1 publications. South China Morning Post: 12½ years’ jail for ex-Macau lawmaker Au Kam-san in city’s first national security trial.
Who is covering it
- South China Morning Post Hong Kong 12½ years’ jail for ex-Macau lawmaker Au Kam-san in city’s first national security trial Former Macau lawmaker Au Kam-san has been convicted on five out of seven charges in the city’s first national security trial, with the court handing down a 12½-year prison sentence. The Court of First Instance in Macau on Friday found the 69-year-old guilty on four counts under the city’s national s 1 h ago · Tier 2
Headlines and excerpts are the publishers' own, shown under quotation for review and linked to the originals.
More from World
Two new Ebola vaccines to join DR Congo clinical trial
The World Health Organization has approved clinical trials for two new Ebola vaccines against the Bundibugyo virus strain, according to Punch and Africanews. Africanews and Medical Xpress report the approval came on Wednesday, as doctors fight an outbreak that has killed more than 5,300 people. UN News reports the two vaccine candidates will be added to a clinical trial in the Democratic Republic of the Congo, which is battling the outbreak. The sources do not give details of the trial timetable, the vaccine developers or the number of participants. Summary from 5 sources
Summary from 5 sources UN News first also Punch, Africanews, Medical Xpress
WORLD IN BRIEF: Tech stocks lose $2.5tn, Paraguay president resigns, DR Congo residents sue Chinese mine over pollution and other stories
BusinessDay published a world news roundup headlined with three items: tech stocks losing $2.5tn, the Paraguayan president resigning, and DR Congo residents suing a Chinese mine over pollution. According to the excerpt, major technology stocks suffered heavy losses on Thursday as AI concerns deepened after the US midterms. The supplied excerpts contain no further detail on the Paraguay resignation or the DR Congo lawsuit, so those items cannot be expanded from this material. Both supplied sources are the same BusinessDay item, so no outlets disagree. Summary from 2 sources
Summary from 2 sources BusinessDay first
British man infected with Ebola in DR Congo arrives in UK for treatment
According to MyJoyOnline, a British man who tested positive for Ebola in the Democratic Republic of Congo will be flown back to the UK. The BBC reported that he has arrived in the UK for treatment. The BBC quoted the UK government saying there are "well-established procedures for dealing with cases like this" and that the risk to the public remains low. The sources supplied do not give further details on his condition or on the flight. Summary from 3 sources
Summary from 3 sources BBC Health first also BBC News, MyJoyOnline